+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Smart Insulin Pen Market Research Report by Type (First Generation Pens and Second Generation Pens), Usability, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5124031
  • Report
  • April 2022
  • Region: United States
  • 110 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Berlin-Chemie AG
  • Companion Medical Inc.
  • Diamesco Co., Ltd.
  • Eli Lilly and Company
  • Insulet Corporation
  • Novo Nordisk A/S
The United States Smart Insulin Pen Market size was estimated at USD 7.03 million in 2021, USD 8.59 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 18.44% to reach USD 19.41 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Smart Insulin Pen to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across First Generation Pens and Second Generation Pens. The Second Generation Pens is further studied across Bluetooth-enabled and USB Connected.
  • Based on Usability, the market was studied across Prefilled and Reusable.
  • Based on End User, the market was studied across Ambulatory Surgical Centers, Home Care Settings, and Hospitals & Clinics.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Smart Insulin Pen Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Smart Insulin Pen Market, including Berlin-Chemie AG, Bigfoot Biomedical, Companion Medical Inc., Diabnext, Diamesco Co., Ltd., Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH E-Health Technologies, F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co. Ltd., Medtronic plc, Novo Nordisk A/S, and Sanofi S.A..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Smart Insulin Pen Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Smart Insulin Pen Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Smart Insulin Pen Market?
4. What is the competitive strategic window for opportunities in the United States Smart Insulin Pen Market?
5. What are the technology trends and regulatory frameworks in the United States Smart Insulin Pen Market?
6. What is the market share of the leading vendors in the United States Smart Insulin Pen Market?
7. What modes and strategic moves are considered suitable for entering the United States Smart Insulin Pen Market?
Frequently Asked Questions about the U.S. Smart Insulin Pen Market

What is the estimated value of the U.S. Smart Insulin Pen Market?

The U.S. Smart Insulin Pen Market was estimated to be valued at $7.0 Million in 2021.

What is the growth rate of the U.S. Smart Insulin Pen Market?

The growth rate of the U.S. Smart Insulin Pen Market is 18.4%, with an estimated value of $19.4 Million by 2027.

What is the forecasted size of the U.S. Smart Insulin Pen Market?

The U.S. Smart Insulin Pen Market is estimated to be worth $19.4 Million by 2027.

Who are the key companies in the U.S. Smart Insulin Pen Market?

Key companies in the U.S. Smart Insulin Pen Market include Berlin, Chemie AG, Bigfoot Biomedical, Companion Medical Inc., Diabnext, Diamesco Co., Ltd., Digital Medics Pty Ltd., Eli Lilly and Company and Health Technologies.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Berlin-Chemie AG
  • Companion Medical Inc.
  • Diamesco Co., Ltd.
  • Eli Lilly and Company
  • Insulet Corporation
  • Novo Nordisk A/S

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Smart Insulin Pen Market, by Type
6.1. Introduction
6.2. First Generation Pens
6.3. Second Generation Pens
6.3.1. Bluetooth-enabled
6.3.2. USB Connected
7. Smart Insulin Pen Market, by Usability
7.1. Introduction
7.2. Prefilled
7.3. Reusable
8. Smart Insulin Pen Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Home Care Settings
8.4. Hospitals & Clinics
9. California Smart Insulin Pen Market10. Florida Smart Insulin Pen Market11. Illinois Smart Insulin Pen Market12. New York Smart Insulin Pen Market13. Ohio Smart Insulin Pen Market14. Pennsylvania Smart Insulin Pen Market15. Texas Smart Insulin Pen Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Berlin-Chemie AG
17.2. Bigfoot Biomedical
17.3. Companion Medical Inc.
17.4. Diabnext
17.5. Diamesco Co., Ltd.
17.6. Digital Medics Pty Ltd.
17.7. Eli Lilly and Company
17.8. Emperra GmbH E-Health Technologies
17.9. F. Hoffmann-La Roche AG
17.10. Insulet Corporation
17.11. Jiangsu Delfu medical device Co. Ltd.
17.12. Medtronic plc
17.13. Novo Nordisk A/S
17.14. Sanofi S.A.
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES SMART INSULIN PEN MARKET: DYNAMICS
FIGURE 2. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMART INSULIN PEN MARKET SIZE, BY TYPE, 2027
FIGURE 5. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY FIRST GENERATION PENS, 2019-2027 (USD MILLION)
FIGURE 6. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY FIRST GENERATION PENS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 7. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2019-2027 (USD MILLION)
FIGURE 8. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 9. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY BLUETOOTH-ENABLED, 2019-2027 (USD MILLION)
FIGURE 10. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY BLUETOOTH-ENABLED, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 11. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY USB CONNECTED, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY USB CONNECTED, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2021 VS 2027 (%)
FIGURE 14. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2021 VS 2027 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2027
FIGURE 16. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY PREFILLED, 2019-2027 (USD MILLION)
FIGURE 17. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY PREFILLED, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY REUSABLE, 2019-2027 (USD MILLION)
FIGURE 19. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY REUSABLE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 21. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SMART INSULIN PEN MARKET SIZE, BY END USER, 2027
FIGURE 23. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY HOME CARE SETTINGS, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY HOSPITALS & CLINICS, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES SMART INSULIN PEN MARKET: FPNV POSITIONING MATRIX
FIGURE 30. UNITED STATES SMART INSULIN PEN MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 31. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES SMART INSULIN PEN MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES SMART INSULIN PEN MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY FIRST GENERATION PENS, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, BY STATE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY BLUETOOTH-ENABLED, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY USB CONNECTED, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY PREFILLED, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY REUSABLE, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES SMART INSULIN PEN MARKET: SCORES
TABLE 16. UNITED STATES SMART INSULIN PEN MARKET: BUSINESS STRATEGY
TABLE 17. UNITED STATES SMART INSULIN PEN MARKET: PRODUCT SATISFACTION
TABLE 18. UNITED STATES SMART INSULIN PEN MARKET: RANKING
TABLE 19. UNITED STATES SMART INSULIN PEN MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 20. UNITED STATES SMART INSULIN PEN MARKET: MERGER & ACQUISITION
TABLE 21. UNITED STATES SMART INSULIN PEN MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 22. UNITED STATES SMART INSULIN PEN MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 23. UNITED STATES SMART INSULIN PEN MARKET: INVESTMENT & FUNDING
TABLE 24. UNITED STATES SMART INSULIN PEN MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 25. UNITED STATES SMART INSULIN PEN MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Berlin-Chemie AG
  • Bigfoot Biomedical
  • Companion Medical Inc.
  • Diabnext
  • Diamesco Co., Ltd.
  • Digital Medics Pty Ltd.
  • Eli Lilly and Company
  • Emperra GmbH E-Health Technologies
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Jiangsu Delfu medical device Co. Ltd.
  • Medtronic plc
  • Novo Nordisk A/S
  • Sanofi S.A.
Note: Product cover images may vary from those shown

Loading
LOADING...